The influence of cell context on the selection pressure for p53 mutation in human cancer.
The influence of cell context on the selection pressure for p53 mutation in human cancer.
Although p53 mutation is, overall, by far the most frequent somatic genetic abnormality in human cancer, in some common tumour types, notably carcinoma of breast, it is seen only in a phenotypically-distinct sub-set of cases, often correlated with adverse prognosis. Conventionally, this is viewed as the consequence of random differences in acquired genetic events acting on a common cell. Here we develop a fundamentally different hypothesis, which proposes that the liability of a given tumour to exhibit p53 mutation is predetermined by the nature of its cell of origin and, more specifically, depends on the extent to which wild-type p53 forms a rate-limiting step in the control of proliferative lifespan in that cell. In other words, the phenotype of the cell of origin constrains both tumour phenotype and 'choice' of genetic events. This concept can be extended to tumour progression, where evidence particularly from thyroid tumorigenesis suggests that a switch in differentiation state can play a major causal role in tumour evolution by altering the selection pressure for p53 mutation. Finally, analysis of transformed thyroid cells has also revealed a novel physiological mechanism by which growth suppression by wild-type p53 may be evaded in cell types whose lifespan control is p53-independent.
29-36
Wynford-Thomas, D
b95cdf4a-87cc-4390-a893-eee9cc7fff5d
Blaydes, J
e957f999-fd91-4f77-ad62-5b4ef069b15b
January 1998
Wynford-Thomas, D
b95cdf4a-87cc-4390-a893-eee9cc7fff5d
Blaydes, J
e957f999-fd91-4f77-ad62-5b4ef069b15b
Wynford-Thomas, D and Blaydes, J
(1998)
The influence of cell context on the selection pressure for p53 mutation in human cancer.
Carcinogenesis, 19 (1), .
Abstract
Although p53 mutation is, overall, by far the most frequent somatic genetic abnormality in human cancer, in some common tumour types, notably carcinoma of breast, it is seen only in a phenotypically-distinct sub-set of cases, often correlated with adverse prognosis. Conventionally, this is viewed as the consequence of random differences in acquired genetic events acting on a common cell. Here we develop a fundamentally different hypothesis, which proposes that the liability of a given tumour to exhibit p53 mutation is predetermined by the nature of its cell of origin and, more specifically, depends on the extent to which wild-type p53 forms a rate-limiting step in the control of proliferative lifespan in that cell. In other words, the phenotype of the cell of origin constrains both tumour phenotype and 'choice' of genetic events. This concept can be extended to tumour progression, where evidence particularly from thyroid tumorigenesis suggests that a switch in differentiation state can play a major causal role in tumour evolution by altering the selection pressure for p53 mutation. Finally, analysis of transformed thyroid cells has also revealed a novel physiological mechanism by which growth suppression by wild-type p53 may be evaded in cell types whose lifespan control is p53-independent.
This record has no associated files available for download.
More information
Published date: January 1998
Identifiers
Local EPrints ID: 150579
URI: http://eprints.soton.ac.uk/id/eprint/150579
ISSN: 0143-3334
PURE UUID: 36f22566-8dc2-419a-a02c-7769e270db9f
Catalogue record
Date deposited: 20 Jul 2010 14:08
Last modified: 23 Jul 2022 01:47
Export record
Contributors
Author:
D Wynford-Thomas
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics